News Room
Bayer Stops Late-Stage Study for Stroke Prevention Due to Lack of Efficacy
By Helena Smolak Bayer is discontinuing early a Phase 3 study to test investigational drug asundexian on prevention of stroke…
Board battles over OpenAI’s future exposed by Sam Altman sacking
OpenAI’s convoluted corporate structure was designed to protect its board of directors from normal commercial pressures and ensure that the…
SoFi Stock Drops Amid Loan Valuation Debate
SoFi Technologies stock has whipsawed in the days since a quarterly filing revived debate about how the fintech values its…
Microsoft hires former OpenAI chief Sam Altman
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Microsoft has…
U.S. Stocks May Have Finally Met Their Match. Here Are 3 Reasons Why.
International stocks could be about to begin a multiyear stretch of outperforming U.S. equities. I say that knowing full well…
Self-driving car venture Cruise chief resigns after uproar over accident
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The co-founder…
Cruise co-founder and CEO Kyle Vogt resigns from robotaxi company
Kyle Vogt resigned as chief executive of autonomous-vehicle company Cruise late Sunday, following the recent suspension of Cruise’s operations on…
OpenAI taps Emmett Shear as chief executive
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.OpenAI’s board…